This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Interdict Bio, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David Gygi and Protein Synthesis Modulation
Introduction
David Gygi is an inventor based in San Francisco, California. His work includes a patent application concerning compounds designed to modulate protein synthesis. He is associated with Interdict Bio, Inc.
Latest Patents
Gygi is named on 1 patent: “Small Molecule Protein Synthesis Modulators.” The disclosure describes compounds and their pharmaceutically acceptable salts for modulating protein synthesis, along with related pharmaceutical compositions and kits. It also outlines methods for treating or preventing diseases and disorders associated with targets including BCL-2, MYC, CCND1, MCL-1, ALK, and KRAS-G12D.
Career Highlights
The patent disclosure reflects research into small-molecule approaches to influencing protein synthesis and potential therapeutic applications. It describes administering the compounds or related compositions to subjects in need of treatment or prevention.
Collaborations
Gygi’s listed coworkers include Sogole Sami Bahmanyar and Lawrence Hamann. His work is associated with Interdict Bio, Inc.
Conclusion
David Gygi’s patent work focuses on protein synthesis modulators and their potential use in addressing diseases associated with specific molecular targets.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile